Bard (C.R.) Inc. (BCR1)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Timothy M. Ring
Employees:
16,300
730 CENTRAL AVE, MURRAY HILL, NJ 07974
9082778000

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

C.R. Bard, Inc. designs, develops, manufactures, distributes and markets medical technologies in the fields of vascular, urology, oncology and surgical specialty products. It sells a range of products to hospitals, individual healthcare professionals, extended care facilities and alternate site facilities. The company was founded by Charles Russell Bard in 1907 and is headquartered in Murray Hill, NJ.

Data derived from most recent annual or quarterly report
Market Cap 24.145 Billion Shares Outstanding72.892 Million Avg 30-day Volume 928.437 Thousand
P/E Ratio40.8464 Dividend Yield0.3247 EPS5.6
Price to Revenue6.0236 Debt to Equity0.8144 EBITDA954.8 Million
Price to Book Value11.5683 Operating Margin25.8889 Enterprise Value23.687 Billion
Current Ratio1.724 EPS Growth0.121 Quick Ratio1.107
1 Yr BETA 0.7628 52-week High/Low 0.0 / Profit Margin14.7469
Operating Cash Flow Growth58.1779 Altman Z-Score5.2319 Free Cash Flow to Firm 687.809 Million
View SEC Filings from BCR1 instead.

View recent insider trading info

Funds Holding BCR1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BCR1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WHITE TONY L

  • Director
0 2017-12-29 0

HENKEL HERBERT L

  • Director
0 2017-12-29 0

WEILAND JOHN H VICE CHAIRMAN, PRES. AND COO

  • Officer
  • Director
No longer subject to file 2017-12-29 0

RING TIMOTHY M CHAIRMAN AND CEO

  • Officer
  • Director
No longer subject to file 2017-12-29 0

WELTERS ANTHONY

  • Director
0 2017-12-29 0

HOLLAND CHRISTOPHER S SENIOR VICE PRESIDENT AND CFO

  • Officer
No longer subject to file 2017-12-29 0

NAUGHTON GAIL K

  • Director
0 2017-12-29 0

THOMPSON TOMMY G

  • Director
0 2017-12-29 0

LUPISELLA FRANK JR VICE PRESIDENT AND CONTROLLER

  • Officer
No longer subject to file 2017-12-29 0

DAVIS ROBERT M

  • Director
0 2017-12-29 0

DEFORD JOHN A SR. VP SCI TECH AND CLIN AFRS

  • Officer
No longer subject to file 2017-12-29 0

KELLY JOHN C.

  • Director
0 2017-12-29 0

MELCHER DAVID F

  • Director
0 2017-12-29 0

LUBOFF SHARON M GROUP VICE PRESIDENT

  • Officer
No longer subject to file 2017-12-29 0

COLLINS TIMOTHY P GROUP PRESIDENT

  • Officer
No longer subject to file 2017-12-29 0

BEASLEY JIM C GROUP PRESIDENT

  • Officer
No longer subject to file 2017-12-29 0

BARRETT DAVID M

  • Director
0 2017-12-29 0

GROETELAARS JOHN P GROUP PRESIDENT

  • Officer
No longer subject to file 2017-12-29 0

KHICHI SAMRAT S. SR. VP, GEN COUNSEL & SECY.

  • Officer
No longer subject to file 2017-12-29 0

LARSON BETTY D VP - HUMAN RESOURCES

  • Officer
No longer subject to file 2017-12-29 0

PORRECA GERARD D III VP, QUALITY, REG & MED AFFAIRS

  • Officer
No longer subject to file 2017-12-29 0

CHRISTIAN PATRICIA G VP -QUALITY, REG & MED AFFAIRS

  • Officer
12,422 2016-02-10 0

BRESLAWSKY MARC C

  • Director
12,655 2015-12-09 0

KELLY BRONWEN K VP - HUMAN RESOURCES

  • Officer
22,420 2014-08-04 0

KREINDLER PETER M SR. VP, GEN COUNSEL & SECY.

  • Officer
No longer subject to file 2014-07-15 0

DOLCH GARY D SR. VP-QUALITY AND REG AFFAIRS

  • Officer
27,466 2013-12-11 0

KELLY BRIAN P GROUP VICE PRESIDENT

  • Officer
No longer subject to file 2013-11-01 0

HOLLOWAY JEAN F VP, GEN COUNSEL AND SECRETARY

  • Officer
11,397 2013-07-26 0

MORFIT G MASON

VALUEACT HOLDINGS, L.P.

VALUEACT CAPITAL MASTER FUND, L.P.

VA PARTNERS I, LLC

VALUEACT CAPITAL MANAGEMENT, L.P.

VALUEACT CAPITAL MANAGEMENT, LLC

VALUEACT HOLDINGS GP, LLC

  • Director
  • SEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKSSEE REMARKS
No longer subject to file 2013-04-17 0

MARTIN THEODORE E

  • Director
0 2013-01-02 0

SCHERMERHORN TODD C SENIOR VICE PRESIDENT AND CFO

  • Officer
86,618 2012-05-04 0

MORFIT G MASON

  • Director
0 2012-01-20 0

LONG STEPHEN J VP, GEN COUNSEL AND SECRETARY

  • Officer
22,520 2011-11-08 0

DUNNIGAN T KEVIN

  • Director
0 2010-12-31 0

NATALE JAMES L SR VP, PRES CORP HLTHCARE SVCS

  • Officer
No longer subject to file 2009-04-03 0

PAUL AMY S GROUP VICE PRESIDENT

  • Officer
No longer subject to file 2008-12-31 0

HOWARD JAMES M II VP-REGULATORY SCIENCES

  • Officer
9,147 2008-07-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments